Xcout Intel
Cyted Health
Cyted Health delivers a diagnostic platform that combines minimally invasive cell collection with high-resolution molecular analysis. This platform is designed to detect early biological markers.
Subscribe to see Cyted Health’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cyted Health at a glance
Cyted Health is a healthcare company headquartered in United Kingdom. Its most recent funding round, Series B, raised $44M in September 2025. Xcout tracks 21 named people at Cyted Health, including Betsy Hanna (President & US General Manager).
Cyted Health leadership
- Betsy HannaPresident & US General Manager
- Neha GoelChief Operating Officer
- Matt MitchoChief Commercial Officer
- Marcel GehrungCo-founder & Chief Executive Officer
- Rebecca FitzgeraldCo-founder & Chair of Scientific Advisory Board
- Dr Maria O’DonovanCo-founder & Lead Pathologist
15 more named people on record for Cyted Health, with roles, board committees and tenure — see the full roster →
Cyted Health funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $44M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Cyted Health news
Investors
Cyted Health competitors
A few of Cyted Health's closest competitors — see the full list of competitors and alternatives →
EarlyDiagnostics, also known as EarlyDx, is a clinical-stage precision diagnostics company that develops non-invasive liquid biopsy technologies and genomics platforms for early cancer detection.
Celsee Diagnostics is a company operating in the rare disease diagnostics and liquid biopsy market. Based in Maryland, the company is involved in developing and assessing advanced healthcare technologies for cancer and genomic detection.
Amoy Dx is a diagnostic company dedicated to transforming cancer care by breaking barriers in precision oncology. The company develops specialized genomic tools and diagnostics products, such as the AmoyDx Essential NGS Panel used in clinical trials. It operates as a visionary enterprise within the precision medicine and diagnostics sector.
Prostatype Genomics develops, manufactures, and markets Prostatype, a prognostic genetic test for prostate cancer. The test combines gene expression data with clinical parameters to assess cancer aggressiveness and help doctors and patients determine appropriate treatment decisions.
Orchid Health, Inc. provides whole-genome embryo screening services for individuals and couples undergoing in vitro fertilization (IVF). The company's testing evaluates embryos for genetic predispositions to thousands of conditions, including cancers, neurodevelopmental disorders, and heart defects, to help patients mitigate hereditary health risks.
Aitiologic is a precision-medicine startup based in Vienna that develops liquid biopsy platforms, including the aitios platform and aitios NIPPT. The company focuses on advanced molecular diagnostics to support personalized healthcare.
Get Cyted Health's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cyted Health in Xcout Intel
- 21 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access